Heparin Monitoring and Patient Safety: A College of American Pathologists Q-Probes Study of 3431 Patients at 140 Institutions | Citedby Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

Heparin Monitoring and Patient Safety: A College of American Pathologists Q-Probes Study of 3431 Patients at 140 Institutions

Arch Pathol Lab Med (2004) 128 (4): 397–402.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis

Gavin Raner
Yirui Hu
Cody Trowbridge
Li Zhang
John Logan
Xianren Wu
Xiaopeng Zhang

Cureus (2024)

Correlation between Thrombin Generation, Standard Coagulation Assays, and Viscoelastic Assays for Hemostatic Assessment in Critically Ill Children

Kimberly A Thomas
Susan M Shea
Arun Saini
Jennifer A Muszynski
Philip C Spinella

The Journal of Applied Laboratory Medicine (2022) 7 (5): 1108.

Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort

Surbhi Saini
Ashley N. Folta
Katherine L. Harsh
Joseph R. Stanek
Amy L. Dunn
Sarah H. O'Brien
Riten Kumar

The Journal of Pediatrics (2019) 209: 212.

Attributable Length of Stay and Mortality of Major Bleeding as a Complication of Therapeutic Anticoagulation in the Intensive Care Unit

Najib T. Ayas
Peter M. Dodek
Hong Wang
Robert Fowler
Hubert Wong
Monica Norena

Journal of Patient Safety (2015) 11 (1): 23.

A Dilemma in the Glycosaminoglycan‐Based Therapy: Synthetic or Naturally Unique Molecules?

Vitor H. Pomin

Medicinal Research Reviews (2015) 35 (6): 1195.

Twenty-Five Years of Accomplishments of the College of American Pathologists Q-Probes Program for Clinical Pathology

Peter J. Howanitz
Peter L. Perrotta
Christine P. Bashleben
Frederick A. Meier
Glenn E. Ramsey
Larry W. Massie
Roberta L. Zimmerman
Donald S. Karcher

Archives of Pathology & Laboratory Medicine (2014) 138 (9): 1141.

A Comparative Trial of Anti-Factor Xa Levels Versus the Activated Partial Thromboplastin Time for Heparin Monitoring

Jeremy W. Vandiver
Thomas G. Vondracek

Hospital Practice (2013) 41 (2): 16.

Heparin toxicity in cell culture

H. Alper Gurbuz
A. Baris Durukan
Handan Sevim
Ekin Ergin
Aylin Gurpinar
Cem Yorgancioglu

Blood Coagulation & Fibrinolysis (2013) 24 (7): 742.

Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin

Jeremy W. Vandiver
Thomas G. Vondracek

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2012) 32 (6): 546.

Meta-Analysis of Safety and Efficacy of Uninterrupted Warfarin Compared to Heparin-Based Bridging Therapy During Implantation of Cardiac Rhythm Devices

Hamid Ghanbari
Wouter Saint Phard
Hazim Al-Ameri
Rakesh Latchamsetty
Krit Jongnarngsin
Thomas Crawford
Eric Good
Aman Chugh
Hakan Oral
Frank Bogun
Fred Morady
Frank Pelosi

The American Journal of Cardiology (2012) 110 (10): 1482.

Laboratory Monitoring of Heparin Therapy: Partial Thromboplastin Time or Anti-Xa Assay?

Christopher M. Lehman
Elizabeth L. Frank

Laboratory Medicine (2009) 40 (1): 47.

Laboratory Monitoring of Heparin: Challenges and Opportunities

Anne M. Winkler
Chelsea A. Sheppard
Corinne R. Fantz

Laboratory Medicine (2007) 38 (8): 499.

Managing Laboratory Test Use: Principles and Tools

Brian R. Jackson

Clinics in Laboratory Medicine (2007) 27 (4): 733.

Routine Bivalirudin Use in Percutaneous Carotid Interventions

Ruth L. Bush
Peter H. Lin
Leila Mureebe
Wei Zhou
Eric K. Peden
Alan B. Lumsden

Journal of Endovascular Therapy (2005) 12 (4): 521.